CEO

Dr J. Nicholas Housby

PhD PGDiP(Oxon)

Experienced biomedical CEO and investor, track record of scaling precision medicine and genomics start-ups

CTO

Dr Robert M. Learney

PhD MRCS

Dual-qualified in medicine and engineering, inventor of Accunea's micro-bioassay technology

COO

Mr Bob Rose

BA Business & Finance

Experienced medical device COO with focus on procurement, manufacturing and supply chain management 

Regulatory Lead

Dr. Paul Bielderman

MD PhD MBA

Expert in medical regulation with long track record managing compliance and oversight in major device and pharmaceutical companies

Founded with a shared belief that real-time functional monitoring has the power to improve many areas of current clinical practice, where a lack of data at the point-of-care, an inability to perform predictive analysis, and a lack of population-level clinical insights are leading to sub-optimal patient outcomes.

​

Accunea seeks to improve confidence and safety when making critical decisions by complementing and enhancing the skills of medical professionals, enabling them to draw upon upon cutting-edge sensor technology, advanced analytics, and design.

Expert Advisory Board

Accunea is complemented and enhanced by knowledge and skills from world-leading experts in biosensing, transplantation, and renal injury

Prof. Martyn G. Boutelle

PhD ARCS

Professor of Biomedical Sensor Engineering at Imperial College London, expert in translational research

Prof. Vassilios Papalois

MD PhD FRCS

Professor of Transplant Surgery at Hammersmith Hospital, Europe's largest kidney transplant centre

Prof. Frederick WK Tam

MBBChir PhD FRCP

Ken and Mary Minton Chair of Renal Medicine at Hammersmith Hospital, expert in acute and chronic renal injury